Our experience with the aetiological diagnosis of global developmental delay and intellectual disability: 2006-2010;Nuestra experiencia en el diagnóstico etiológico del retraso global del desarrollo y discapacidad intelectual: 2006-2010

Neurologia

Volumn 29, Issue 7, 2014, Pages 402-407

  Lopez Pison J ^a   Garcia Jimenez M C ^a   Monge Galindo, L ^a   Lafuente Hidalgo, M ^a   Perez Delgado R ^a   Garcia Oguiza A ^a   Pena Segura J L ^a  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

Global developmental delay; Intellectual disability; Microarray comparative genomic hybridisation

Indexed keywords

ARTICLE; AUTISM; BRAIN DISEASE; CEREBRAL PALSY; CHILD; CHILDHOOD DISEASE; COMPARATIVE GENOMIC HYBRIDIZATION; DEVELOPMENTAL DISORDER; DIAGNOSTIC VALUE; GENETIC DISORDER; GENETIC ENCEPHALOPATHY; GLOBAL DEVELOPMENTAL DELAY; HUMAN; INTELLECTUAL IMPAIRMENT; MAJOR CLINICAL STUDY; METABOLIC DISORDER; VISUAL FIELD DEFECT; WEST SYNDROME; ADOLESCENT; DEVELOPMENTAL DISABILITIES; GENETIC SCREENING; GENETICS; INTELLECTUAL DISABILITY; NEUROLOGY; PRESCHOOL CHILD; PROCEDURES; RETROSPECTIVE STUDY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COMPARATIVE GENOMIC HYBRIDIZATION; DEVELOPMENTAL DISABILITIES; GENETIC TESTING; HUMANS; INTELLECTUAL DISABILITY; NEUROLOGY; RETROSPECTIVE STUDIES;

EID: 84926416032     PISSN: 02134853     EISSN: 15781968     Source Type: Journal    
DOI: 10.1016/j.nrl.2013.10.006     Document Type: Article

References (17)

1. Shevell M., Ashwal S., Donley D., Flint J., Gingold M., Hirtz D., et al. Practice parameter: Evaluation of the child with global developmental delay: Report of the Quality Standards Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society. Neurology 2003, 60:367-380. Quality Standards Subcommittee of the American Academy of Neurology; Practice Committee of the Child Neurology Society.
2. Shevell M. Global developmental delay and mental retardation or intellectual disability: Conceptualization, evaluation and etiology. Pediatr Clin North Am 2008, 55:1071-1084.
3. Schalock RL, Borthwick-Duffy SA, Bradley M, editores. Intellectual disability: Definition, classification, and systems of supports. 11th ed. Washington: American Association on Intellectual and Developmental Disabilities; 2010.
4. Battaglia A., Carey J.C. Diagnostic evaluation of developmental delay/mental retardation: An overview. Am J Med Genet C Semin Med Genet 2003, 117C:3-14.
5. Rauch A., Hoyer J., Guth S., Zweier C., Kraus C., Becker C., et al. Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardation. Am J Med Genet A 2006, 140:2063-2074.
6. Moeschler J.B., Shevell M. Clinical genetic evaluation of the child with mental retardation or developmental delays. Pediatrics 2006, 117:2304.
7. Shevell M.I. A "global" approach to global developmental delay end intellectual disability?. Dev Med Child Neurol 2011, 53:105-106.
8. van Karnebeek C.D., Jansweijer M.C., Leenders A.G., Offringa M., Hennekam R.C. Diagnostic investigations in individuals with mental retardation: A systematic literature review of their usefulness. Eur J Hum Genetic 2005, 13:6-25.
9. Moeschler J.B. Medical genetics diagnostic evaluation of the child with global developmental delay or intellectual disability. Curr Opin Neurol 2008, 21:117-122.
10. Moeschler J.B., Amato R.S., Brewster T., Burke L., Dinulos M.B., Smith R., et al. Improving genetic health care: A Northern New England pilot project addressing the genetic evaluation of the child with developmental delays or intellectual disability. Am J Med Genet C Semin Med Genet 2009, 151C:241-254.
11. Michelson D.J., Shevell M.I., Sherr E.H., Moeschler J.B., Gropman A.L., Ashwal S. Evidence Report: Genetic and metabolic testing on children with global developmental delay: Report of the Quality Standards. Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2011, 77:1629-1635.
12. López-Pisón J., Rebage V., Arana T., Baldellou A., Arcauz P., Peña-Segura J.L. A study of the demand for neuropediatric services in a general hospital II. Reasons for consultation. Rev Neurol 1997, 25:1685-1688.
13. López-Pisón J., Arana T., Baldellou A., Rebage V., García-Jiménez M.C., Peña-Segura J.L. Demand for neuropediatric services in a general referral hospital iii. Diagnosis. Rev Neurol 1997, 25:1896-1905.
14. López-Pisón J., Arana T., Rebage V., Baldellou A., Alija M., Peña-Segura J.L. Demand for neuropediatric care in a regional general hospital v. Complementary tests. Rev Neurol 1998, 26:208-214.
15. Klee E.W., Hoppman-Chaney N.L., Ferber M.J., Expanding D.N.A. Diagnostic panel testing: Is more better?. Expert Rev Mol Diagn 2011, 11:703-709.
16. Proposal for a Council recommendation on a European action in the field of rare diseases /* COM/2008/0726 final - CNS 2008/0218 */. Disponible en: http://eur-law.eu/EN/Proposal-Council-recommendation-European-action-field-rare-diseases, 501668,d.
17. Estrategia en Enfermedades Raras del Sistema Nacional de Salud. Estrategia aprobada por el Consejo Interterritorial del Sistema Nacional de Salud el 3 de junio de 2009. Sanidad 2009. Ministerio de Sanidad y Política Social. Disponible en: . http://www.msc.es/organizacion/sns/planCalidadSNS/docs/enfermedadesRaras.pdf.